Radiation Oncology

Prof. Dr. Yılmaz Tezcan

Doctor and researcher Ankara Bilkent Şehir Hastanesi Ankara
Lung NeoplasmsUterine Cervical NeoplasmsBreast NeoplasmsLiver Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Lung Neoplasms 3 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Uterine Cervical Neoplasms 2 publications
  • Breast Neoplasms 2 publications
  • Liver Neoplasms 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyRadiation Oncologysaglik.gov.trFrom source
  • InstitutionAnkara Bilkent Şehir Hastanesisaglik.gov.trFrom source
  • Area of workLung NeoplasmsExtracted from 3 publications · Model version —From source
  • Publications73 publicationsORCID, Europe PMC, OpenAlexFrom source
  • ORCID0000-0003-3698-1640ORCIDFrom source
  • Last synchronised7 November 2026 00:02https://ankarasehir.saglik.gov.tr/TR-327896/radyasyon-onkolojisi-klinigi-doktorlarimiz.html#yilmaz-tezcansaglik.gov.tr

Scientific work

Publications on Lung Neoplasms

73 publications

  1. The Role of Stereotactic Body Radiotherapy in Geriatric Patients With Oligometastatic Cancer: A Geriatric Oncology Perspective

    Clinical Oncology, 2026

    DOI 10.1016/j.clon.2026.104173 PMID 42127825 Source: ORCID

  2. Primary tonsillar kaposi sarcoma in an HIV-negative, immunocompetent patient: A case-based review

    Irish journal of medical science, 2026

    DOI 10.1007/s11845-026-04515-8 PMID 42321559 Source: Europe PMC

  3. Pre-treatment MRI-derived fractal dimension as a prognostic marker in cervical cancer treated with definitive radiotherapy with or without concurrent chemotherapy

    BMC medical imaging, 2026

    DOI 10.1186/s12880-026-02589-5 PMID 42464209 Open-access full textSource: Europe PMC

  4. Adult Intracranial Ependymal Tumors: Results of TROD Neurooncology Group 07-009 Study

    Turkish Neurosurgery, 2026

    DOI 10.5137/1019-5149.jtn.49161-26.4 Source: OpenAlex

  5. Outcomes of Radiotherapy for WHO Grade 2 Meningioma: Survival, Local Control, and Prognostic Factors

    Medicina, 2026

    DOI 10.3390/medicina62081523 PMID 42654420 Open-access full textSource: OpenAlex

  6. Effects of melatonin, amifostine and thymoquinone on liver Na + /K + -ATP’ase enzyme activity in total body irradiated rats

    Turkish Journal of Biochemistry, 2026

    DOI 10.1515/tjb-2025-0180 Open-access full textSource: OpenAlex

  7. Postoperative glioblastoma: the effect of radiotherapy timing on prognosis

    ecancermedicalscience, 2026

    DOI 10.3332/ecancer.2026.2189 Open-access full textSource: OpenAlex

  8. Re: prognostic value of the glucose-to-lymphocyte ratio in surgically treated endometrial cancer

    Future Oncology, 2026

    DOI 10.1080/14796694.2026.2734058 PMID 42748223 Open-access full textSource: OpenAlex

  9. Survival Prediction in Brain Metastasis Patients Treated with Stereotactic Radiosurgery: A Hybrid Machine Learning Approach

    Brain Sciences, 2025

    DOI 10.3390/brainsci15030266 PMID 40149787 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  10. Breast cancer radiotherapy: analysis of unintended internal mammary node doses and influencing factors

    Revista da Associacao Medica Brasileira (1992), 2025

    DOI 10.1590/1806-9282.20241325 PMID 40172395 Open-access full textSource: Europe PMC

View all 73 publications